Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDI-192 for Atopic Dermatitis in Children and Adolescents
NCT01826461Phase 2Completed
- Sponsor
- PreCision Dermatology, Inc.
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PDI-192 in atopic dermatitis (AD) (3 arms), sponsored by PreCision Dermatology, Inc. Primary endpoint: Treatment Success based on change in Investigator's Global Assessment at 29 days. Started Mar 2013; status: completed.
02
Drugs
PDI-192
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01826461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01826461.